3 completed, 2 terminated, 1 unknown. 3 Phase 3, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow tarenflurbil: new trials by email Literature Review of tarenflurbil trials Research Report on tarenflurbil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TMP001 in Relapsing-remitting Multiple Sclerosis TMP001 - Remitting-Relapsing Multiple Sclerosis | Phase 2 | Completed | Dr. Frank Behrens | 9 | 2015-08-01 | 2018-11-21 |
| Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects R-flurbiprofen - Healthy Volunteers | Phase 1 | Completed | Gerd Geisslinger | 16 | 2014-06-01 | 2015-09-11 |
| Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol MPC-7869 - Alzheimer's Disease | Phase 3 | Terminated | Myrexis Inc. | 1000 | 2006-09-01 | 2008-08-05 |
| Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's MPC-7869 - Alzheimer Disease, Dementia | Phase 3 | Terminated | Myrexis Inc. | 800 | 2006-05-01 | 2008-08-05 |
| Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's MPC-7869 - Alzheimer Disease, Dementia | Phase 3 | Completed | Myrexis Inc. | 1600 | 2005-02-01 | 2009-05-05 |
| R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence tarenflurbil, adjuvant therapy - Prostate Cancer | Phase 2 | Unknown | Myrexis Inc. | 2002-02-01 | 2013-12-18 |
Alzheimer Disease (3) · Dementia (3) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Prostatic Neoplasms (1)
Myrexis Inc. (4) · Dr. Frank Behrens (1) · Gerd Geisslinger (1)
United States (4) · Germany (3) · Canada (2) · Belgium (1) · Denmark (1) · France (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Mark Laughlin, MD (2) · Ed Swabb, MD (1) · Gerd Geisslinger, Prof MD (1) · Sheron B. Bass, RN, MS (1) · Ulf Ziemann, MD (1)